The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; none of the 73 sources its claims cite is checked for support yet.
Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins
Open accessAbstract
Human papillomaviruses (HPV) are believed to be the primary causal agents for development of pre‐neoplastic and malignant lesions of the uterine cervix, and high‐risk types such as type 16 and 18 are associated with more than 90% of all cervical carcinomas. The E6 and E7 genes of HPV are thought to play causative roles, since E6 promotes the degradation of p53 through its interaction with E6AP, an E3 ubiquitin ligase, whereas E7 binds to the retinoblastoma protein (pRb) and disrupts its complex formation with E2F transcription factors. Although prophylactic vaccines have become available, it is still necessary to clarify the mechanisms of HPV‐induced carcinogenesis because of the widespread nature of HPV infection. Approximately 493 000 new cases of cervical cancer are diagnosed each year with approximately 274 000 mortalities due to invasive cervical cancer. In the present article, the mechanisms of HPV16 E6‐ and E7‐induced multistep carcinogenesis and recently identified functions of these onco‐proteins are reviewed. (Cancer Sci 2007; 98: 1505–1511)
Overview
CoChat Summary
Written by AI from the paper’s full text.
TL;DR
This review summarizes how high-risk HPV E6 and E7 oncoproteins drive cervical carcinogenesis by inactivating p53 and pRb family proteins and by targeting additional cellular pathways. It emphasizes that overexpression of E6/E7, usually after viral integration, is a bottleneck step that cooperates with further genetic and epigenetic changes.
Key findings
- High-risk HPV types (16, 18, 31, 33, 45, 51, 52, 58, etc.) are associated with more than 90% of cervical cancers; HPV16 accounts for approximately half and HPV18 for another 10–20%. Approximately 493,000 new cervical cancer cases and 274,000 deaths occur annually.
- E6 promotes degradation of p53 through interaction with E6AP, an E3 ubiquitin ligase, while E7 binds pRb family proteins and disrupts pRb–E2F complexes; together they cause polyploidy and genomic instability.
- E6 has p53-independent functions, including hTERT/telomerase induction and degradation of PDZ-domain proteins such as DLG, Scribble, MUPP1, MAGI-1/-2/-3, GIPC, PATJ, PTPN3, and PSD95; E7 targets many proteins including p27, p21, p600, and PP2A.
- Integration and high-level E6/E7 expression are proposed as the bottleneck step; additional events reported in cervical cancers include PIK3CA, c-myc, ErbB2, and cIAP1 amplification, ras mutation, and decreased PTEN and TSLC1 expression.
Methods
- Narrative review; no primary experimental data, sample, or systematic analysis are reported.
- Synthesizes published literature and the authors’ recent work on HPV16 E6- and E7-induced multistep carcinogenesis, the HPV life cycle, and target proteins of E6 and E7 (Table 1; Figs 1–5).
Limitations
- The paper does not state formal limitations; it notes that further exploration is needed for TSC2/Tuberin as a possible E6 target.
- Evident from the text: this is a narrative review without stated systematic search or inclusion criteria, and some mechanistic claims rely on cited reviews, speculation, or a personal communication (A. Suhrbier, 2007) regarding E7-mediated pRb cleavage.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
57 Sources not found · 14 Own interpretation
In the paper
“The most manifest function of the E6 protein is to promote the degradation of p53 through its interaction with a cellular protein, E6 associated protein (E6AP), an E3 ubiquitin ligase (9)”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > The functions of HPV onco-proteins E6 and E7
What the sources say
- Not matchedcites [9]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“in the presence of E6, a repressor complex of TERT promoter, containing USF1 and USF2, is replaced by Myc, which corresponds to higher levels of TERT transcription and consequently, telomerase activity.(35)”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > The functions of HPV onco-proteins E6 and E7
What the sources say
- Not matchedcites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“The interaction of E7 with cyclin-dependent kinase (CDK)2/cyclin A, (60) as well as CDK2/cyclin E, (61) has also been reported.”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > IRF1
What the sources say
- Not matchedcites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“For evasion of the immune system, E7 also interacts with p48, (64) as well as IRF1.(8)”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > IRF1
What the sources say
- Not matchedcites [64]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“E6 and Myc interaction has been shown to activate the telomerase reverse transcriptase promoter, (34)”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > The functions of HPV onco-proteins E6 and E7
What the sources say
- Not matchedcites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
- Probably not a substantial claim. 9
- It may state two separate claims as one. 18
Create a free account to see these claims.
Create a free account to see these assumptions.
42 more claims
Create a free account to see all 71 claims and every source verdict.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > Tyk2
“TSC2 (tubulin)”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > The functions of HPV onco-proteins E6 and E7
“The tumor suppressor gene TSC2 product, Tuberin”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > HPV infection and HPV-induced transformation
“The ultimate development of cervical cancer is rarely accompanied by high expression of E6 and E7 proteins.”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > HPV infection and HPV-induced transformation
“CIN III (severe dysplasia, carcinoma in situ) and invasive cancer lesions often display high-level expression of E6 and E7”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > The functions of HPV onco-proteins E6 and E7
“Therefore, its down regulation through p53 with E6/E6AP has been revealed as a novel tumor suppressor mechanism blocking development of HPV-induced cervical carcinogenesis.”
§ Basic mechanisms of high-risk human papillomavirusinduced carcinogenesis: Roles of E6 and E7 proteins > The functions of HPV onco-proteins E6 and E7
“its down-regulation by E6 might contribute to the development of cervical cancer.”
Citations
Cites
Epidemiologic classification of human papillomavirus types associated with cervical cancer
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., Snijders, P. J. F., & Meijer, C. J. L. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021641 · Cited by 6,249
Papillomaviruses and cancer: from basic studies to clinical application
Hausen, H. Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc798 · Cited by 4,094
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,691
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C. A., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 971
Notch1 functions as a tumor suppressor in mouse skin
Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C., Clevers, H. C., Dotto, G. P., & Radtke, F. (2003) · Nature Genetics · doi:10.1038/ng1099 · Cited by 969
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation
Rangarajan, A., Talora, C., Okuyama, R., Nicolas, M., Mammucari, C., Oh, H., Aster, J. C., Krishna, S., METZGER, D., Chambon, P., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3427 · Cited by 867
The Ets family of transcription factors
Wasylyk, B., Hahn, S. L., & Giovane, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 839
Mechanisms of human papillomavirus-induced oncogenesis
Münger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M., & Huh, K. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11451-11460.2004 · Cited by 815
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Cited by
Items 301–400 of 530
Therapeutic Efficacy of a VSV-GP-based Human Papilloma Virus Vaccine in a Murine Cancer Model
Riepler, L., Frommelt, L.-S., Wilmschen, S., Mbuya, W., Held, K., Volland, A., von Laer, D., Geldmacher, C., & Kimpel, J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168096 · Cited by 9
Liverani, C. A., Ciavattini, A., Monti, E., Puglia., D., Mangano, S., Giuseppe, J. D., Zizzi, A., Goteri, G., & Bolis, G. (2012) · Europe PMC (PubMed Central) · Cited by 9
Juglone Inhibits Proliferation of HPV-Positive Cervical Cancer Cells Specifically
Zhao, X., Song, X., Zhao, J., Zhu, W., Hou, J., Wang, Y., & Zhang, W. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00845 · Cited by 9
Chauhan, S., Sen, S., Singh, N., Sharma, A., Pushker, N., Kashyap, S., & Chawla, B. V. (2019) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2019.03.001 · Cited by 9
Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs
Bhattacharjee, R., Kumar, L., Dhasmana, A., Mitra, T., Dey, A., Malik, S., Kim, B., & Gundamaraju, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.977933 · Cited by 9
Molecular basis of cervical carcinogenesis by high-risk human papillomaviruses
Yugawa, T., & Kiyono, T. (2008) · Uirusu · doi:10.2222/jsv.58.141 · Cited by 9
Self-citationKorzun, T., Moses, A. S., Diba, P., Sattler, A. L., Olson, B. G., Taratula, O. R., Pejovic, T. B., Marks, D. L., & Taratula, O. (2023) · Small · doi:10.1002/smll.202301776 · Cited by 8
Bonello, K., & Blundell, R. A. (2016) · International Journal of Medical Students · doi:10.5195/ijms.2016.146 · Cited by 8
Zhang, Y., Zhu, F., Chen, C., Chen, S., Huang, X. L., Wang, Y., Qiu, P., Deng, G., & Gao, J. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2020.1836242 · Cited by 8
Study on the methylation status of SPINT2 gene and its expression in cervical carcinoma
Wang, N., Che, Y., Yin, F., Yu, F., Bi, X., & Wang, Y. (2018) · Cancer Biomarkers · doi:10.3233/cbm-171050 · Cited by 8
Huang, J., Diao, G., Zhang, Q., Chen, Y., Han, J., & Guo, J. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4983 · Cited by 8
Mudhigeti, N., Kalawat, U., Hulikal, N., & Racherla, R. G. (2021) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2021.11.009 · Cited by 8
Impact of human papilloma virus in patients with oral and oropharyngeal squamous cell carcinomas
Valls-Ontañón, A., Hernández‐Losa, J., Somoza, R., Bellosillo, B., y Cajal, S. R., Bescós, C., Munill, M., & Alberola‐Ferranti, M. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.01.005 · Cited by 8
Therapies and nanotherapies for cervical cancer (Review)
Sánchez‐Meza, L. V., Bello‐Rios, C., Gómez‐Gómez, Y., Leyva‐Vázquez, M. A., Araujo‐Arcos, L. E., Duque, J. A. V., Organista‐Nava, J., & Illades‐Aguiar, B. (2025) · Biomedical Reports · doi:10.3892/br.2025.2010 · Cited by 7
Downham, L., Rol, M. L., Forestier, M., Romero, P., Mendoza, L. P., Mongelós, P., Picconi, M. A., Colucci, M. C., Padín, V. M., Flores, A. P., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34953 · Cited by 7
The interaction between human papilloma viruses related cancers and non-coding RNAs
Ghafouri‐Fard, S., Hussen, B. M., Shaterabadi, D., Abak, A., Shoorei, H., Taheri, M. N., & Rakhshan, A. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153939 · Cited by 7
Virus del papiloma humano: aspectos moleculares y cáncer de cérvix
Grillo‐Ardila, C. F., Martínez-Velásquez, M. Y., & Morales-López, B. (2008) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.395 · Cited by 7
Wu, C., Horowitz, D. P., Deutsch, I., Rahmati, R., Schecter, J. M., Saqi, A., & Wang, T. J. C. (2015) · Oncology Letters · doi:10.3892/ol.2015.3836 · Cited by 7
Derbie, A., Mekonnen, D. S., Woldeamanel, Y., Ostade, X. V., & Abebe, T. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.507 · Cited by 7
Gao, Z., Gu, N., Wu, M., Wang, S.-Y., Xu, H., Li, Q., & Wu, G. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211067111 · Cited by 7
Erira, H. A. T., Vargas, L. A. M., Chala, A., Moreno, A., Gamboa, F., & Robayo, D. A. G. (2015) · Biomédica · doi:10.7705/biomedica.v36i0.2912 · Cited by 7
Zhou, Z., Sturgis, E. M., Liu, Z., Wang, L., Wei, Q., & Li, G. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.21838 · Cited by 7
Liu, L., Yu, T., Ren, C., Yang, L., Cui, S., & Zhang, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27109 · Cited by 7
RetractedXu, J., Yang, W., Xie, X., Gu, C., Zhao, L., Liu, F., Zhang, N., Bai, Y., Liu, D., Liu, H., et al. (2024) · PeerJ · doi:10.7717/peerj.18157 · Cited by 6
Pathogenetic Action of Viruses in Head and Neck Cancer
Litsou, E. V. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1008249 · Cited by 6
Human Papillomavirus in Oral Lichen Planus of Japanese Patients
Kato, S., Kawai, R., Isomura, M., Sato, N., Yoshida, W., Kamiya, K., Nagaya, Y., Hattori, T., Sato, E., Sugita, Y., et al. (2015) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.24.181 · Cited by 6
Go, S.-H., Rho, S. B., Yang, D.-W., Kim, B.-R., Lee, C. H., & Lee, S. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.108 · Cited by 6
Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms
Jarych, D., Mikulski, D., Wilczyński, M., Wilczyński, J. R., Kania, K., Haręża, D. A., Malinowski, A., Perdas, E., Nowak, M., & Paradowska, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020762 · Cited by 6
Detection of Human Papillomavirus 33 in Erosive Oral Lichen Planus
Farhadi, S., Sadri, D., Bandehpour, M., Akbari, M., Jafarzadeh, E., & Hashemi, M. (2020) · International Journal of Cancer Management · doi:10.5812/ijcm.101488 · Cited by 6
Multiple HPV subtypes infection in Japanese oral squamous cell carcinoma
Ono, K., Sugahara, K., Nomura, T., Takano, N., Shibahara, T., & Katakura, A. (2013) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2013.01.001 · Cited by 6
Jin, Y., Choi, J. W., Kim, H. J., Eddouzi, J., Kim, S. C., Ju, W., Kim, Y. H., & Kim, H. (2018) · Cancer Medicine · doi:10.1002/cam4.1810 · Cited by 6
Arab, A., Amini, F., Iraji, A., & Hashempur, M. H. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106873 · Cited by 5
Kumar, S., Yadav, P., Maurya, A., Yadav, S. C., & Prasad, T. (2026) · ChemistrySelect · doi:10.1002/slct.202505590 · Cited by 5
Arega, S., Dey, S., Pani, S., Dash, S. R., Budhwar, R., Kundu, C. N., & Ganguly, N. (2024) · Genomics · doi:10.1016/j.ygeno.2024.110957 · Cited by 5
کنارکوهی, ع., جاهی, ح. س., فلاحی, ش., مدوار, ح. ر., & مشکات, ز. (2011) · مجله دانشگاه علوم پزشکی اراک · Cited by 5
Sinha, A., Ghosh, A., Ghosh, A., Mathai, S., Bhaumik, J., Mukhopadhyay, A., Maitra, A., Biswas, N. K., & Sengupta, S. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01651-9 · Cited by 5
A Novel Mutant of Human Papillomavirus Type 18 E6E7 Fusion Gene and its Transforming Activity
Zhou, Z., Zhao, C., Li, Q., & Zeng, Y. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.17.7395 · Cited by 5
Naykı, C., Günay, M., Külhan, M., Naykı, Ü., Çankaya, M., & Kulhan, N. G. (2017) · Ginekologia Polska · doi:10.5603/gp.a2017.0067 · Cited by 5
KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.
Dai, L., Qiao, J., Valle, L. D., & Qin, Z. (2018) · Europe PMC (PubMed Central) · Cited by 5
HPV-Induced Oropharyngeal Cancer and the Role of the E7 Oncoprotein Detection via Brush Test
Borena, W., Schartinger, V. H., Dudás, J., Ingruber, J., Greier, M. C., Steinbichler, T. B., Laimer, J., Stoiber, H., Riechelmann, H., & Kofler, B. (2020) · Cancers · doi:10.3390/cancers12092388 · Cited by 5
Quinlan, S. F., May, S. P., Weeks, R. D., Yuan, H., & Luff, J. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.570982 · Cited by 5
Bidaki, M. Z., Zardast, M., Nadjafi-Semnani, A., Nadjafi-Semnani, M., Javanmard, D., Ghafari, S., & Ghanbarzadeh, N. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07276-8 · Cited by 5
Suwiwat, S., Tungsinmunlong, K., & Siriaungkul, S. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.7.2431 · Cited by 5
Nin, D. S., Yew, C. W., Tay, S. K., & Deng, L. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0019 · Cited by 5
Wu, Y., Xia, H., Du, F., Zhang, J., Jiang, X., Tang, J., & Li, Z. (2025) · Health Science Reports · doi:10.1002/hsr2.70704 · Cited by 4
Transforming Properties of E6/E7 Oncogenes from Beta-2 HPV80 in Primary Human Fibroblasts
Renteria-Flores, F. I., Molina-Pineda, A., Piña-Cruz, R., Vizcarra-Ramos, S., Vega‐Magaña, N., García‐Chagollán, M., Magaña‐Torres, M. T., Hernández‐Gutiérrez, R., Aguilar‐Lemarroy, A., & Jave‐Suárez, L. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115347 · Cited by 4
SQSTM1/p62 drives radiosensitivity in cervical cancer via autophagy-independent mechanisms
Yoshida, M., Nunomura, H., Furuta, A., Yamada, K., Yasuda, I., Takemura, K., Tsuda, S., Yamaki‐Ushijima, A., Shima, T., Ogawa, R., et al. (2025) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2025.104633 · Cited by 4
Salazar-Ulbrich, N., Haro-Solis, D., Aguayo, F., Quezada-Monrás, C., Cárcamo, L. T., Collado, L., & Carrillo-Beltrán, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052272 · Cited by 4
Ghosh, A., Sinha, A., Ghosh, A., Roy, S., Mallick, S., Kumar, V., Mathai, S., Bhaumik, J., Mukhopadhyay, A., Sen, S., et al. (2024) · Human Genomics · doi:10.1186/s40246-024-00660-2 · Cited by 4
Strategies for delivery of antiviral agents
Khwaza, V., Buyana, B., Nqoro, X., Peter, S., Mbese, Z., Feketshane, Z., Alven, S., & Aderibigbe, B. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91814-5.00018-0 · Cited by 4
Teffera, Z. H., Belay, W. Y., Tegegne, B. A., Misganaw, B., Abebaw, D., Belayineh, M., Akelew, Y., Dilnessa, T., Adugna, A., Silabat, B., et al. (2024) · World Academy of Sciences Journal · doi:10.3892/wasj.2024.267 · Cited by 4
Pandey, P., Ramniwas, S., Pandey, S., Lakhanpal, S., Ballal, S., Kumar, S., Bhat, M., Sharma, S., Kumar, M., & Khan, F. (2024) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2691 · Cited by 4
Screening for gynecological cancers
Kalsi, J., Manchanda, R., & Menon, U. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.13.5 · Cited by 4
Casagrande, D. C., Ribalta, J. C. L., Leite, K. D. P. F., Schimidt, M. A., & Speck, N. M. D. G. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15017916 · Cited by 4
Serological Biomarkers for the Prediction and Detection of Human Papillomavirus Associated Cancers
Gutiérrez‐Xicoténcatl, L., Salazar-Piña, D. A., Chihu-Amparán, L., & Pedroza-Saavedra, A. (2018) · InTech eBooks · doi:10.5772/intechopen.75143 · Cited by 4
Current Perspectives in Human Papilloma Virus: Where We are and What We Need?
Devi, B. S. A., Bovilla, V. R., & Madhunapantula, S. V. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1798 · Cited by 4
Elkhaligy, H., Balbin, C. A., & Siltberg-Liberles, J. (2022) · Pathogens · doi:10.3390/pathogens11050583 · Cited by 4
Influence of pathogens on host genome and epigenome in development of head and neck cancer
Desai, S. (2023) · Cancer Reports · doi:10.1002/cnr2.1846 · Cited by 4
Feng, H., & Deng, Y. (2023) · International Journal of Public Health · doi:10.3389/ijph.2023.1605284 · Cited by 4
Taniyama, K., Jhala, D. N., Katayama, H., Kuraoka, K., Naito, Z., Rangdaeng, S., Gong, G., Lai, C., Chang, A. R., & Jhala, N. C. (2010) · Diagnostic Cytopathology · doi:10.1002/dc.21418 · Cited by 4
Wulandari, D., Rachmadi, L., & Sudiro, T. M. (2015) · Medical Journal of Indonesia · doi:10.13181/mji.v24i4.1197 · Cited by 4
Utami, T. W. (2018) · Global Journal of Reproductive Medicine · doi:10.19080/gjorm.2018.04.555635 · Cited by 4
Pathogenesis of Oncoviruses: A Systemic Review
Abedien, Z. U., Gul, K., Khan, S., Shafiq, M., Rahman, K., & Nawaz, M. H. (2023) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2303.03006 · Cited by 3
Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment
Sebutsoe, X., Tsotetsi, N. J. N., Jantjies, Z. E., Raphela-Choma, P. P., Choene, M. S., & Motadi, L. R. (2024) · OncoTargets and Therapy · doi:10.2147/ott.s475132 · Cited by 3
Mao, X., & Yang, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1624047 · Cited by 3
HPV as a Model for the Development of Prophylactic and Therapeutic Cancer Vaccines
Samara, R. N., & Khleif, S. N. (2009) · Current Molecular Medicine · doi:10.2174/156652409788970625 · Cited by 3
Genetic Polymorphisms of Essential Immune Pathogenic Response Genes and Risk of Cervical Cancer
Nissar, S., Aga, S. S., & Banday, M. Z. (2021) · Springer eBooks · doi:10.1007/978-981-33-6699-2_7 · Cited by 3
Fan, W., Yu, M., Wang, X., Xie, W., Tian, R., Cui, Z., Jin, Z., Huang, Z., Das, B. C., Severinov, K., et al. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00355-z · Cited by 3
Alfaifi, M. S. (2024) · Cureus · doi:10.7759/cureus.57851 · Cited by 3
CRISPR-Cas based genome editing for eradication of human viruses
Solanki, D., Murjani, K., & Singh, V. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.07.012 · Cited by 3
[Study advance of relationship between HPV and lung cancer].
Guo, F., Fan, Y., Qiao, Y., & Zhou, Q. (2012) · PubMed Central · doi:10.3779/j.issn.1009-3419.2012.03.11 · Cited by 3
Mischo, A., Ohlenschläger, O., Ramachandran, R., & Görlach, M. (2012) · Biomolecular NMR Assignments · doi:10.1007/s12104-012-9374-1 · Cited by 3
Yang, M., Zhu, H., Hu, T., Liu, S., & Wang, H. (2015) · Europe PMC (PubMed Central) · Cited by 3
Discordant Reports of miRNA Expression in Cervical Cancer: An Upshot of Overlapping Factors
Okoye, J. O. (2015) · Research In Cancer and Tumor · Cited by 3
Han, F., Li, Y., Lu, Q.-N., Ma, L., Wang, H., Jiang, J., Li, Z., & Li, Y. (2017) · Virology Journal · doi:10.1186/s12985-017-0806-5 · Cited by 3
Human Papillomavirus–Related Malignancies in the Setting of Posttransplantation Immunosuppression
Stiebing, B. N., Rosado, F., & Vos, J. A. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0586-ra · Cited by 3
Recurrent Respiratory Papillomatosis: an Extensive Review
Valerie, A., & Kalodimou, V. E. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Prevalence of Human Papillomavirus in Laryngeal Squamous Cell Carcinoma in Azerbaijan Population
Aliyev, A. J., Melikova, L. A., Bagirova, E. E., Akbarov, K., Aliyeva, A. M., & Quliyev, N. A. (2018) · Head and Neck Cancer Research · doi:10.21767/2572-2107.100024 · Cited by 3
Antonishyn, N. A. (2007) · oURspace (University of Regina) · doi:10.82465/6454 · Cited by 3
Urinary Tract Infections: Virus
LUCIANI, L. G., & Mattevi, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00139-7 · Cited by 3
The Achilles Heel of Cervical Cancer: An Overlooked Target?
González, A. D. (2012) · Journal of Pharmacogenomics & Pharmacoproteomics · doi:10.4172/2153-0645.1000e128 · Cited by 2
Human papillomavirus infection in non-cervical sites in India
Nithyanandhan, K., Mammen, S., & Abraham, P. (2025) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2025.100948 · Cited by 2
Yamaji, M., Nakahara, T., Nakanishi, T., Aoyama‐Kikawa, S., Yamaguchi, K., Furukawa, Y., Nakamura, M., Okada, T., Tabata, H., Fuse, R., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178685 · Cited by 2
Self-citationLi, Q., Huang, W., Du, X., & Zhu, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1707853 · Cited by 2
Anuudari, E., Kawai, R., Kato, S., Yoshida, W., Kamiya, K., Nagaya, Y., Hattori, T., Sugita, Y., Kubo, K., & Maeda, H. (2014) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.23.149 · Cited by 2
VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia
Rotar, I. C., Dumitraş, D. E., Popp, R. A., Petrişor, F. M., Cotutiu, P., Stamatian, F. V., & Mureșan, D. (2016) · Analytical Cellular Pathology · doi:10.1155/2016/6074275 · Cited by 2
Valilou, S. F., & Keshavarz‐Fathi, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814039-0.00010-2 · Cited by 2
Back to the clinic: without a rationale there is no worthy research question
Talavera, J. O., Rivas-Ruíz, R., Pérez‐Rodríguez, M., Roy-García, I. A., & Palacios‐Cruz, L. (2019) · Gaceta Médica de México · doi:10.24875/gmm.m19000250 · Cited by 2
Current Update on the Risk Factor Modification and Excercise Following Coronary Artery Disease
Rahmianti, N. D., Yusrizal, T., & Farabi, M. J. A. (2020) · Biomolecular and Health Science Journal · doi:10.20473/bhsj.v3i1.17994 · Cited by 2
Norlida, M., Abdullah, H., Hapidin, H., & Fatmawati, M. N. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.110310 · Cited by 2
Usman, M., Ahmad, M., Hameed, Y., Ahmed, H., Hussain, M. S., Rehman, J. U., Arshad, R., & Atif, M. (2021) · INTERNATIONAL JOURNAL OF ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR) · doi:10.29052/ijehsr.v9.i2.2021.248-256 · Cited by 2
Hygiene, J. O. P. M. A. (2023) · PubMed Central · doi:10.15167/2421-4248/jpmh2022.63.3s2 · Cited by 2
ZNF281 Facilitates the Invasion of Cervical Cancer Cell Both In Vivo and In Vitro
Chong, Y., Zhang, K., Zeng, Y., Chen, Q., Feng, Q., Cui, N., Zheng, P., Ruan, L., & Hua, W. (2024) · Cancers · doi:10.3390/cancers16213717 · Cited by 2
Noorani, R., Botting‐Provost, S., Barsoum, G. H., Laurie, C., El‐Zein, M., & Franco, E. L. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102781 · Cited by 2
Future of RNAi-Based Therapies for Human Papillomavirus-Associated Cervical Cancer
Chen, J., Irving, A. T., McMillan, N. A. J., & Gu, W. (2007) · Future Virology · doi:10.2217/17460794.2.6.587 · Cited by 2
The lifecycle of HPV governed by the differentiation program of epithelial cell
Satsuka, A., & Sakai, H. (2008) · Uirusu · doi:10.2222/jsv.58.165 · Cited by 2
Momonaka, M., Hayashida, K., & Hayashida, N. (2016) · Biomedical Research and Clinical Practice · doi:10.15761/brcp.1000124 · Cited by 2
Balducci, G. (2017) · Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons · doi:10.11138/gchir/2017.38.5.229 · Cited by 2
Falcucci, S., Paolini, F., Mileo, A. M., Franconi, R., Massa, S., Rinaldi, A., & Venuti, A. (2021) · ACS Omega · doi:10.1021/acsomega.0c03976 · Cited by 2
Human Polyomaviruses and Papillomaviruses
Moens, U. L. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-221-1 · Cited by 2
Metadata
- Authors
- Narisawa‐Saito, M., & Kiyono, T.
- Affiliations
- National Cancer Center Research Institute (JP)
- Corresponding author
- Kiyono, Tohru
- ORCID
- Kiyono, Tohru
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2007-07-23
- Volume
- 98
- Issue
- 10
- Pages
- 1505-1511
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- PMC
- PMC11158331
- OpenAlex
- W2011499737
- Cited by
- 528
- References
- 85
- Citations by year
- 2026: 13 · 2025: 27 · 2024: 46 · 2023: 24 · 2022: 33 · 2021: 43 · 2020: 32 · 2019: 24 · 2018: 36 · 2017: 27 · 2016: 23 · 2015: 25 · 2014: 25 · 2013: 26 · 2012: 27
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, HPV16, HPV 18, cervical cancer, carcinogenesis, E6 oncoprotein, E7 oncoprotein, p53 degradation, UBE3A, retinoblastoma protein, E2F transcription factors, viral oncogenesis, HPV vaccine
- MeSH terms
- Cell Transformation, Neoplastic, Cell Transformation, Viral, Uterine Cervical Neoplasms, Female, Humans, Oncogene Proteins, Viral, Repressor Proteins, Papillomaviridae, Papillomavirus Infections, Papillomavirus E7 Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
